Catherine C. Park, MD

Associate Professor, Department of Radiation Oncology, UCSF

Phone: (415) 353-9807 (appts)
Box 1708, UCSF
San Francisco, CA 94143-1708

View on UCSF Profiles

Additional Websites

• Physician Referral Directory

Education

University of California, Berkeley, CA, B.A., 1989, History of Art
UCLA School of Medicine, Los Angeles, CA, M.D., 1995, Medicine
Beth Israel Hospital, Harvard Medical School, Boston, MA, 1996, Internship, Internal Medicine
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA, 2000, Residency, Radiation Oncology

Professional Experience

• 1998-1999
  Research Associate, Lawrence Berkeley National Laboratory, Berkeley, CA
• 2000-2006
  Visiting Scientist, Lawrence Berkeley National Laboratory, Berkeley, CA
• 2006-present
  Faculty Biologist, Lawrence Berkeley National Laboratory, Berkeley, CA
• 2000-2008
  Assistant Professor, UCSF, Department of Radiation Oncology
• 2008-present
  Associate Professor, UC San Francisco, Department of Radiation Oncology, San Francisco, CA
• 2009
  Faculty Member, UCSF Institute for Molecular Medicine, San Francisco, CA

Honors & Awards

• 1994
  Alpha Omega Alpha
• 1995
  AMWA Janet M. Glascow Memorial Achievement Citation
• 1995
  C. Donald O'Malley Prize in the History of Medicine
• 1995
  Dean's Scholar, Thesis Program UCLA School of Medicine
• 1995
  Upjohn Achievement Award
• 2002
  Travel Award, Junior Investigator, International Society for Differentiation, Lyon, France
• 2002
  Invited Lecturer, European Society for Therapeutic Radiation Oncology, Prague, CZ
• 2003
  Junior Investigator Award, European Society for Therapeutic Radiation Oncology
• 2003
  Basic Science Junior Investigator Award, American Society for Therapeutic Radiation Oncology
• 2005
  Association of American Medical Colleges Early Career Faculty Women's Professional Development Seminar, Santa Fe, NM

Selected Publications

1. Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):963-72.
   View on PubMed
2. Descovich M, Fowble B, Bevan A, Schechter N, Park C, Xia P. Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys. 2010 Jan 1; 76(1):91-9.
   View on PubMed
3. Hattangadi J, Park C, Rembert J, Klifa C, Hwang J, Gibbs J, Hylton N. Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol. 2008 Jun; 190(6):1630-6.
   View on PubMed
4. Park CK, Miller C, Lawrence G. Addison's disease from non-Hodgkin's lymphoma with normal-size adrenal glands. J Clin Oncol. 2007 Jun 1; 25(16):2322-4.
   View on PubMed
5. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 2007 Jan 15; 67(2):659-64.
   View on PubMed
6. Coleman J, Park C, Villarreal-Barajas JE, Petti P, Faddegon B. A comparison of Monte Carlo and Fermi-Eyges-Hogstrom estimates of heart and lung dose from breast electron boost treatment. Int J Radiat Oncol Biol Phys. 2005 Feb 1; 61(2):621-8.
   View on PubMed
7. Park C, Seid P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong SP. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J. 2005 Jan-Feb; 11(1):29-33.
   View on PubMed

View on UCSF Profiles